Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ABF Associated British Foods	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,041.09 +0.5%	GBX 1,330 ➝ GBX 1,550	Sell
ADBE Adobe	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$285.75 +2.1%	$250.00 ➝ $295.00	Equal Weight
AESI Atlas Energy Solutions	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.11 +0.6%	$21.00 ➝ $17.00	Buy
AFRM Affirm	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$74.30 +0.3%	$83.00 ➝ $85.00	Buy
AGX Argan	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$413.51 +0.8%	$600.00	Hold ➝ Buy
AI C3.ai	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.94 +4.0%		Market Perform
AI C3.ai	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.94 +4.0%		Hold
AI C3.ai	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.94 +4.0%	$10.00	Hold
AI C3.ai	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.94 +4.0%		Market Perform
AIN Albany International	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Arment Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.45 +6.2%	$64.00 ➝ $75.00	Neutral
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ALMS Alumis	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yatin Suneja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.36 +9.8%		Buy ➝ Neutral
AMAL Amalgamated Financial	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Moss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.04 +1.9%	$55.00	Outperform
AMZN Amazon.com	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.90 +1.5%	$328.00 ➝ $338.00	Overweight
ARGX argenex	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,053.46 -0.2%	$1,150.00	Outperform
ASST Strive	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.82 +10.3%	$16.00 ➝ $26.00	Buy
ASST Strive	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.82 +10.3%		Buy
AT Ashtead Technology	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 340 +2.1%	GBX 560 ➝ GBX 400	Sector perform
ATD Alimentation Couche-Tard	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$95.00 ➝ C$90.00	Market Perform
ATD Alimentation Couche-Tard	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$105.00 ➝ C$100.00
ATD Alimentation Couche-Tard	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$110.00 ➝ C$103.00	Buy
ATD Alimentation Couche-Tard	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$108.00 ➝ C$102.00	Buy
ATD Alimentation Couche-Tard	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$102.00 ➝ C$101.00	Outperform
ATD Alimentation Couche-Tard	Target Lowered by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$81.91 -0.4%	C$104.00 ➝ C$102.00	Sector Outperform
ATLC Atlanticus	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.71 +3.1%	$111.00 ➝ $119.00	Buy
ATLC Atlanticus	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$96.71 +3.1%		Buy
AVGO Broadcom	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%		Buy
AVGO Broadcom	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%		Buy ➝ Hold
AVGO Broadcom	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$357.16 -2.7%		Buy
AVGO Broadcom	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%		Sector Perform ➝ Outperform
AVGO Broadcom	Upgraded by	Fox Advisors Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$357.16 -2.7%		Outperform
AVGO Broadcom	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$400.00	Sector Perform
AVGO Broadcom	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$550.00 ➝ $520.00	Buy
AVGO Broadcom	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sajal Dogra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$500.00 ➝ $600.00	Buy
AVGO Broadcom	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harsh Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$455.00 ➝ $575.00	Outperform
AVGO Broadcom	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$525.00 ➝ $600.00	Overweight
AVGO Broadcom	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$575.00	Overweight
AVGO Broadcom	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$502.00 ➝ $505.00	Overweight
AVGO Broadcom	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Lipacis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$578.00
AVGO Broadcom	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$500.00 ➝ $475.00	Buy
AVGO Broadcom	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$357.16 -2.7%	$450.00 ➝ $475.00	Outperform
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free
AXON Axon Enterprise	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Staszak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$538.15 +6.1%	$460.00 ➝ $600.00	Buy
AZN AstraZeneca	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£121.52 +1.5%	£160	Buy
B Barrick Mining	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Hacking Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.76 +3.7%	$41.00 ➝ $45.00	Neutral
BARC Barclays	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 489.85 +1.3%	GBX 620	Buy
BASFY Basf	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.54 +0.5%		Buy
BIIB Biogen	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$224.51 +0.8%	$225.00 ➝ $245.00	Overweight
BLTE Belite Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$171.09 +6.5%		Buy
BLTE Belite Bio	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$171.09 +6.5%		Buy
BMA Macro Bank	Downgraded by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$79.11 +0.1%		Outperform ➝ Market Perform
BMNR BitMine Immersion Technologies	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.35 +14.3%	$25.00 ➝ $30.00	Buy
BMNR BitMine Immersion Technologies	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.35 +14.3%		Buy
BMO Bank of Montreal	Target Lowered by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$243.56 +1.8%	C$272.00 ➝ C$261.00	Neutral
BNS Bank of Nova Scotia	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$130.77 +1.3%	C$136.00 ➝ C$137.00	Neutral
BNS Bank of Nova Scotia	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$130.77 +1.3%	C$119.00 ➝ C$120.00
BOKF BOK Financial	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Winter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.35 +0.9%	$150.00	Neutral
BP BP	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.58 -0.8%	$43.00 ➝ $46.00	Neutral
BWXT BWX Technologies	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$160.08 +2.8%	$181.00	Buy
CASY Casey's General Stores	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$758.42 +0.6%	$975.00 ➝ $833.00	Neutral
CBLL CeriBell	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.57 -1.0%	$29.00	Strong-Buy
CBNK Capital Bancorp	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$36.65 +0.6%		Market Perform
CCHGY Coca-Cola HBC	Downgraded by	Investec Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$61.79 +0.4%		Hold
CCJ Cameco	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$100.56 +4.3%	$138.00	Buy
CCO Cameco	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$138.65 +3.9%	C$190.00	Buy
CCO Cameco	Target Set by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$138.65 +3.9%	C$190.00	Buy
CHPT ChargePoint	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.13 +75.9%		Hold
CHPT ChargePoint	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.13 +75.9%		Market Perform
CHPT ChargePoint	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Itay Michaeli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.13 +75.9%		Hold
CIEN Ciena	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Leopold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$316.20 -10.7%	$600.00	Outperform
CIEN Ciena	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$316.20 -10.7%	$375.00
CIEN Ciena	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$316.20 -10.7%	$600.00 ➝ $520.00	Buy
CLYM Climb Bio	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julian Harrison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.59 -3.1%	$20.00 ➝ $32.00	Buy
CLYM Climb Bio	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colleen Kusy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.59 -3.1%	$21.00 ➝ $25.00	Outperform
CLYM Climb Bio	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yasmeen Rahimi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.59 -3.1%	$40.00	Overweight
CM Canadian Imperial Bank of Commerce	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$163.00 +1.8%	C$153.00 ➝ C$154.00
CME CME Group	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$282.05 +1.5%	$292.00	Buy
COST Costco Wholesale	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$925.41 -0.3%	$1,000.00	Neutral
COST Costco Wholesale	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$925.41 -0.3%	$1,125.00	Buy
CPB Campbell's	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.13 -6.9%	$20.00
CPRT Copart	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.58 +4.4%	$40.00
CPRT Copart	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jash Patwa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.58 +4.4%	$32.00 ➝ $40.00	Neutral ➝ Overweight
CRN Cairn Homes	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 245.50 +4.9%	GBX 245	Buy
CTTAY Continental	Upgraded by	Oddo Bhf Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.13 +2.3%		Neutral ➝ Outperform
CVS CVS Health	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.14 -0.1%	$126.00 ➝ $118.00	Buy
CVSA Adtalem Global Education	Downgraded by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Bibb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.95 -4.6%	$140.00	Buy ➝ Hold
CVX Chevron	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Phillip Jungwirth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$211.45 -0.2%	$210.00 ➝ $235.00	Outperform
CVX Chevron	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Margolin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$211.45 -0.2%	$226.00 ➝ $230.00	Overweight
CVX Chevron	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$211.45 -0.2%	$207.00 ➝ $243.00	Overweight
CXM Sprinklr	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.24 -10.2%	$6.00 ➝ $8.00	Neutral
CXM Sprinklr	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.24 -10.2%	$8.50	Buy
CXM Sprinklr	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.24 -10.2%	$6.00 ➝ $6.50	Neutral
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
CXM Sprinklr	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elizabeth Porter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.24 -10.2%	$7.00 ➝ $8.00	Equal Weight
CXM Sprinklr	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.24 -10.2%	$7.50
CXM Sprinklr	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.24 -10.2%		Neutral
DAKT Daktronics	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$19.48 +1.8%	$33.00	Buy
DASH DoorDash	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$222.00 -1.9%		Outperform
DASH DoorDash	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$222.00 -1.9%		Buy
DBX Dropbox	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.70 +3.5%	$42.00	Outperform
DELL Dell Technologies	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gianmarco Conti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$512.66 +4.2%	$520.00	Hold
DKNG DraftKings	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ian Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.19 -0.1%	$27.00 ➝ $29.00	Outperform
DML Denison Mines	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.69 +5.4%	C$5.20	Buy
DNLM Dunelm Group	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 865.50 +4.0%	GBX 850 ➝ GBX 1,050	Buy
DNN Denison Mine	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.41 +5.9%		Buy
DOO BRP	Upgraded by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$64.22 +1.5%		Sector Perform ➝ Outperform
DRTS Alpha Tau Medical	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lukas Shumway Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.62 +2.0%	$17.00 ➝ $30.00	Overweight
DY Dycom Industries	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Frank Louthan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$294.46 -0.8%	$375.00
DYLLF Deep Yellow	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.18 +7.3%	$2.05	Outperform
ECEL Eurocell	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 122 -1.2%	GBX 240	Buy
EIX Edison International	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Sunderland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.29 +2.0%	$77.00 ➝ $63.00	Hold
EMAN Everyman Media Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 57 +1.8%		Under review
ENQ EnQuest	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 25.35 -7.3%	GBX 41	House Stock
EQB EQB	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$133.97 +4.1%	C$128.00 ➝ C$127.00
EU enCore Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.26 +3.3%	$1.44	Buy
FCEL FuelCell Energy	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dushyant Ailani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.67 +1.9%		Buy
FCEL FuelCell Energy	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Gianarikas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.67 +1.9%	$30.00	Buy
FERG Ferguson	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$223.31 +0.9%	$295.00
FISV Fiserv	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan C. Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.73 +1.4%	$55.00	Hold
FIVE Five Below	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$235.00 ➝ $300.00	Equal Weight
FIVE Five Below	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$325.00 ➝ $368.00	Overweight
FIVE Five Below	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$273.00 ➝ $297.00	Buy
FIVE Five Below	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$250.00 ➝ $290.00	Buy
FIVE Five Below	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$235.00 ➝ $265.00	Neutral
FIVE Five Below	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Bellinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$295.00
FIVE Five Below	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krisztina Katai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$401.00
FIVE Five Below	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Randal Konik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$350.00 ➝ $420.00	Buy
FIVE Five Below	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$239.96 -1.3%	$260.00
FIVE Five Below	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$285.00 ➝ $325.00	Buy
FIVE Five Below	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$260.00 ➝ $295.00	Overweight
FIVE Five Below	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$280.00 ➝ $305.00	Outperform
FIVE Five Below	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Hamblin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.96 -1.3%	$325.00	Buy
FLNC Fluence Energy	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Cho Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.20 -3.4%	$16.00 ➝ $10.00	Equal Weight ➝ Underweight
FLOC Flowco	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.42 -1.6%	$30.81 ➝ $27.00	Neutral
FLUT Flutter Entertainment	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ian Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.26 +0.3%		Market Perform
FLUT Flutter Entertainment	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$102.26 +0.3%	$110.00
FNLPF Fresnillo	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.30 +3.9%		Equal Weight ➝ Underweight
FROG JFrog	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.61 -1.2%	$115.00	Buy
FROG JFrog	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.61 -1.2%	$118.00	Outperform
FROG JFrog	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.61 -1.2%	$120.00	Buy
FWDI Forward Industries	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.68 +6.7%	$7.00 ➝ $9.00	Buy
FWDI Forward Industries	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.68 +6.7%		Buy
GBG GB Group	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 160.40 +3.9%	GBX 365 ➝ GBX 300	Speculative Buy
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
GGAL Grupo Financiero Galicia	Downgraded by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.63 -0.8%		Outperform ➝ Market Perform
GIII G-III Apparel Group	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.23 -4.4%	$38.00 ➝ $32.00	Market Perform
GLO Global Atomic	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$0.54 +1.9%	C$0.60	Hold
GLXY Galaxy Digital	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.50 +10.1%	$37.00 ➝ $48.00	Overweight
GOLD Gold.com	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian McNamara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.67 -4.9%	$70.00 ➝ $65.00	Buy
GOLD Gold.com	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.67 -4.9%	$60.00	Buy
GOLD Gold.com	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Gibas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.67 -4.9%	$55.00
GOOGL Alphabet	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.48 +1.6%	$410.00	Buy
GVDNY Givaudan	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.52 +3.2%		Buy
HAE Haemonetics	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.66 -0.3%	$105.00 ➝ $125.00	Outperform
HCM HUTCHMED	Upgraded by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.11 +17.2%		Hold ➝ Buy
HFG Hilton Food Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 708 +12.2%		House Stock
HIND Vyome	Initiated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keay Nakae Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.23 +2.3%	$3.50	Buy
HPE Hewlett Packard Enterprise	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$65.00 ➝ $59.00	Neutral
HPE Hewlett Packard Enterprise	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$67.00 ➝ $54.00	Equal Weight
HPE Hewlett Packard Enterprise	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$69.00 ➝ $67.00	Overweight
HPE Hewlett Packard Enterprise	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Niknam Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$69.00 ➝ $70.00	Buy
HPE Hewlett Packard Enterprise	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$74.00 ➝ $76.00	Buy
HPE Hewlett Packard Enterprise	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$67.00 ➝ $79.00	Overweight
HPE Hewlett Packard Enterprise	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$63.00 ➝ $57.00	Neutral
HPE Hewlett Packard Enterprise	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Leopold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.25 +4.7%	$74.00 ➝ $86.00	Outperform
HQY HealthEquity	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$98.78 +0.2%		Strong-Buy
HSDT Solana	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.35 +13.0%	$2.50 ➝ $3.50	Buy
HSDT Solana	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.35 +13.0%		Buy
ILMN Illumina	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jasper Hellweg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$221.66 +3.9%	$180.00 ➝ $235.00	Buy
IMAX IMAX	Target Raised by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Handler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.85 +0.3%	$50.00 ➝ $60.00	Buy
JD JD Sports Fashion	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 82 -2.4%	GBX 95	Hold
JET2 Jet2	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,512.36 +3.8%	GBX 1,750 ➝ GBX 1,800	Buy
JFB JFB Construction	Initiated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Sullivan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.95 +4.4%	$10.00	Buy
JILL J.Jill	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.33 +0.8%	$14.00 ➝ $18.00	Market Perform
LEU Centrus Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$170.50 -0.6%	$169.00	Buy ➝ Hold
LII Lennox International	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$385.43 +3.1%	$450.00 ➝ $375.00	Underweight
LILAK Liberty Global	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonardo Olmos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.68 +0.6%	$9.00	Neutral
MDT Medtronic	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$92.87 +0.7%	$92.00	Hold
MDT Medtronic	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Priya Sachdeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.87 +0.7%	$100.00 ➝ $110.00	Buy
MELI MercadoLibre	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marvin Fong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,991.06 -0.8%	$2,150.00	Buy
MGNI Magnite	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.63 -1.0%	$25.00 ➝ $30.00	Buy
MIR Mirion Technologies	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.74 +7.5%	$20.00	Buy
MIST Milestone Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.21 +2.5%		Buy
MMED MiniMed Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kallum Titchmarsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.84 +0.3%	$19.00 ➝ $21.00	Overweight
MOTR Motorpoint Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 130	GBX 170	Buy
MPC Marathon Petroleum	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$387.66 +0.2%	$344.00 ➝ $462.00	Overweight
MRNA Moderna	Downgraded by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$148.87 -1.3%	$40.00 ➝ $81.00	Neutral ➝ Sell
MRNA Moderna	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$148.87 -1.3%		Neutral ➝ Sell
MRNA Moderna	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$148.87 -1.3%	$81.00
MSFT Microsoft	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$510.12 +2.7%		Overweight
MSTR Strategy	Reiterated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.82 +17.6%		Buy
MSTR Strategy	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.82 +17.6%	$155.00 ➝ $175.00	Buy
NA National Bank of Canada	Target Lowered by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$217.90 +1.8%	C$249.00 ➝ C$242.00	Outperformer
NA National Bank of Canada	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$217.90 +1.8%	C$224.00 ➝ C$228.00
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
NA National Bank of Canada	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$217.90 +1.8%	C$212.00 ➝ C$213.00
NAKA KindlyMD	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fedor Shabalin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.31 +8.2%	$9.00 ➝ $11.00	Buy
NBIX Neurocrine Biosciences	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.35 +0.4%	$249.00 ➝ $253.00	Buy
NIO NIO	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.85 -0.3%		Sector Perform
NRSN NeuroSense Therapeutics	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lander Egaña Gorroño Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.40 -2.2%		Buy
NTAP NetApp	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$185.00 ➝ $195.00	Neutral
NTAP NetApp	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bryson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$150.00 ➝ $170.00	Neutral
NTAP NetApp	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$209.00 ➝ $190.00	Neutral
NTAP NetApp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$173.00 ➝ $191.00	Equal Weight
NTAP NetApp	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krish Sankar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$200.00	Buy
NTAP NetApp	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$185.38 +2.6%	$210.00	Buy
NTAP NetApp	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$180.00 ➝ $190.00	Equal Weight
NTAP NetApp	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%		Positive
NTAP NetApp	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$199.00 ➝ $219.00	Overweight
NTAP NetApp	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$160.00 ➝ $171.00	Neutral
NTAP NetApp	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nehal Chokshi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.38 +2.6%	$171.00 ➝ $187.00	Outperform
NTIOF National Bank of Canada	Reiterated by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.20 +2.9%		Outperform
NTSK Netskope	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$14.00 ➝ $16.00	Overweight
NTSK Netskope	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$13.00 ➝ $18.00	Outperform
NTSK Netskope	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$18.00 ➝ $20.00	Overweight
NTSK Netskope	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$16.00 ➝ $18.00	Overweight
NTSK Netskope	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$18.00 ➝ $20.00	Outperform
NTSK Netskope	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$17.00 ➝ $18.00	Buy
NTSK Netskope	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$18.00 ➝ $19.00	Buy
NTSK Netskope	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.34 +4.3%	$18.00 ➝ $20.00	Outperform
NVST Envista	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lilia-Celine Lozada Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.53 +0.5%	$29.00 ➝ $32.00	Neutral ➝ Overweight
NVST Envista	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.53 +0.5%	$32.00
NXE NexGen Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.69 +4.6%		Buy
NXE NexGen Energy	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$14.73 +4.3%	C$21.00	Buy
OKE ONEOK	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Spiro Dounis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.76 -0.3%	$97.00 ➝ $108.00	Buy
OLLI Ollie's Bargain Outlet	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$98.00
OLLI Ollie's Bargain Outlet	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$121.00 ➝ $124.00	Outperform
OLLI Ollie's Bargain Outlet	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$100.00 ➝ $90.00	Overweight
OLLI Ollie's Bargain Outlet	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$108.00 ➝ $98.00	Equal Weight
OLLI Ollie's Bargain Outlet	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$112.00 ➝ $100.00	Buy
OLLI Ollie's Bargain Outlet	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$113.00 ➝ $100.00	Overweight
OLLI Ollie's Bargain Outlet	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley B. Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%		Overweight
OLLI Ollie's Bargain Outlet	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$98.00
OLLI Ollie's Bargain Outlet	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.69 -0.2%	$80.00 ➝ $85.00	Buy
OLLI Ollie's Bargain Outlet	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$73.69 -0.2%	$120.00	Buy
ON onsemi	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.65 +1.8%	$110.00 ➝ $95.00	Overweight
ORKA Oruka Therapeutics	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$90.99 -0.7%	$120.00
ORKA Oruka Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.99 -0.7%	$120.00	Buy
OVID Ovid Therapeutics	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.78 +2.6%	$8.00	Buy
PAA Plains All American Pipeline	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.52 -0.8%	$24.00 ➝ $27.00	Neutral
PAGP Plains GP	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.68 -2.4%	$24.00 ➝ $27.00	Neutral
PANW Palo Alto Networks	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Bonner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$331.94 +1.1%	$425.00	Buy
PATH UiPath	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.09 +0.6%	$15.00 ➝ $22.00	Buy
PCG Pacific Gas & Electric	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.94 +4.6%	$23.00 ➝ $18.00	Overweight
PCG Pacific Gas & Electric	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.94 +4.6%	$14.00
PCG Pacific Gas & Electric	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Sunderland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.94 +4.6%	$21.00 ➝ $17.00	Buy ➝ Hold
PETS Pets at Home Group	Initiated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 210.86 +0.3%	GBX 265	Buy
PFG Principal Financial Group	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Krueger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.51 +6.5%		Market Perform
PGY Pagaya Technologies	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$22.89 +4.0%	$26.00	Buy
PHR Phreesia	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Halsted Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.07 -6.6%	$19.00	Outperform
PHR Phreesia	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.07 -6.6%	$16.00	Buy
PHR Phreesia	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stan Berenshteyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.07 -6.6%	$9.00 ➝ $10.00	Equal Weight
PLTK Playtika	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.24	$4.50 ➝ $4.00	Buy
PRU Prudential	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,020.14 +1.7%	GBX 1,445	Buy
PS Pershing Square	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.92 +1.2%	$39.00 ➝ $41.00	Neutral
PS Pershing Square	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.92 +1.2%	$34.00 ➝ $36.00	Equal Weight
PSX Phillips 66	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.61 -0.6%	$209.00 ➝ $264.00	Neutral
PUK Prudential Public	Target Set by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Huttner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.31 +3.7%	$39.30	Buy
PVH PVH	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Nikic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.80 +0.7%	$102.00 ➝ $95.00	Buy
PVH PVH	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.80 +0.7%	$84.00 ➝ $83.00	Underweight
RARE Ultragenyx Pharmaceutical	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$50.00 ➝ $18.00	Overweight ➝ Equal Weight
RARE Ultragenyx Pharmaceutical	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anupam Rama Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$80.00 ➝ $36.00	Overweight ➝ Neutral
RARE Ultragenyx Pharmaceutical	Reiterated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joel Beatty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$40.00 ➝ $16.00	Outperform ➝ Neutral
RARE Ultragenyx Pharmaceutical	Downgraded by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.85 -44.0%	$16.00	Outperform ➝ In-Line
RARE Ultragenyx Pharmaceutical	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$50.00 ➝ $25.00	Buy
RARE Ultragenyx Pharmaceutical	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Kluska Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$103.00 ➝ $33.00	Overweight
RARE Ultragenyx Pharmaceutical	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sami Corwin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%		Outperform ➝ Market Perform
RARE Ultragenyx Pharmaceutical	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whitney Ijem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$83.00 ➝ $37.00	Buy
RARE Ultragenyx Pharmaceutical	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$30.00 ➝ $23.00	Neutral
RARE Ultragenyx Pharmaceutical	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yaron Werber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$49.00 ➝ $18.00	Buy
RARE Ultragenyx Pharmaceutical	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.85 -44.0%		Buy ➝ Neutral
RARE Ultragenyx Pharmaceutical	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maury Raycroft Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$77.00 ➝ $28.00	Buy
RARE Ultragenyx Pharmaceutical	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.85 -44.0%	$58.00 ➝ $28.00	Buy
REPYY Repsol	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.81 +0.6%		Outperform
RNG RingCentral	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.40 +5.3%	$85.00	Outperform
RY Royal Bank of Canada	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$292.37 +1.6%	C$268.00 ➝ C$271.00
RY Royal Bank of Canada	Target Lowered by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$292.37 +1.6%	C$311.00 ➝ C$300.00	Neutral
SGI Somnigroup International	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Silverstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.56 +2.6%	$94.00 ➝ $102.00	Buy
SGI Somnigroup International	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.56 +2.6%	$95.00 ➝ $100.00	Overweight
SHEL Shell	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.31 -0.5%	$89.00 ➝ $100.00	Neutral
SHEL Shell	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martijn Rats Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.31 -0.5%	$101.30	Equal Weight ➝ Overweight
SLF Sun Life Financial	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Heal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.73 +1.6%	$81.00 ➝ $88.00	Buy
SMMT Summit Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.13 +17.3%		Neutral
SNOW Snowflake	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$450.00
SNOW Snowflake	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$400.00 ➝ $475.00	Outperform
SNOW Snowflake	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$372.00 ➝ $440.00	Outperform
SNOW Snowflake	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$430.00	Outperform
SNOW Snowflake	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$320.00 ➝ $440.00	Sector Outperform
SNOW Snowflake	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$405.00 ➝ $430.00	Overweight
SNOW Snowflake	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$425.00
SNOW Snowflake	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$320.00 ➝ $450.00	Overweight
SNOW Snowflake	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$332.00 ➝ $384.00	Equal Weight
SNOW Snowflake	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$300.00 ➝ $470.00	Overweight
SNOW Snowflake	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$330.00 ➝ $450.00	Buy
SNOW Snowflake	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$350.00 ➝ $450.00	Buy
SNOW Snowflake	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacWilliams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$500.00 ➝ $525.00	Overweight
SNOW Snowflake	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$400.00
SNOW Snowflake	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$385.00 ➝ $430.00	Buy
SNOW Snowflake	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Leopold Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$275.00 ➝ $425.00	Outperform
SNOW Snowflake	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$395.00 ➝ $490.00	Buy
SNOW Snowflake	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%		Neutral
SNOW Snowflake	Target Raised by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$380.00 ➝ $450.00	Buy
SNOW Snowflake	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$408.00 ➝ $488.00	Market Outperform
SNOW Snowflake	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$340.00 ➝ $424.00	Buy
SNOW Snowflake	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$325.00 ➝ $450.00	Buy
SNOW Snowflake	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$300.00 ➝ $450.00	Buy
SNOW Snowflake	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$425.00 ➝ $500.00	Buy
SNOW Snowflake	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arti Vula Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$285.00 ➝ $426.00	Overweight
SNOW Snowflake	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$370.00 ➝ $450.00	Buy
SNOW Snowflake	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%		Buy
SNOW Snowflake	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.78 +16.7%	$375.00 ➝ $425.00	Buy
SOLS Solstice Advanced Mat	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.37 +0.6%	$86.00	Buy
SON Sonoco Products	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Staphos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.77 -3.6%	$69.00 ➝ $60.00	Buy ➝ Neutral
SRE Sempra Energy	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Sunderland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.38 +0.7%	$100.00 ➝ $96.00	Buy
SSE SSE	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,375 +0.7%	GBX 2,650	Buy
SSEZY SSE	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.18 +0.7%		Outperform
TCOM Trip.com Group	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.40 -5.1%		Buy ➝ Hold
TD Toronto-Dominion Bank	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$169.90 +1.0%	C$197.00 ➝ C$196.00
TD Toronto-Dominion Bank	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$169.90 +1.0%	C$164.00 ➝ C$165.00
TD Toronto-Dominion Bank	Target Raised by	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$169.90 +1.0%	C$184.00 ➝ C$188.00	Neutral
TEAM Atlassian	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$194.68 +4.4%	$180.00 ➝ $230.00	Buy
TLSA Tiziana Life Sciences	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.97 +4.6%		Buy
TMO Thermo Fisher Scientific	Initiated by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Luo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$618.91 +1.7%	C$748.00	Outperform
TRAX First Tracks Biotherapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.51 -6.1%	$57.00	Buy
TTE TotalEnergies	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.22 -1.1%	$84.00 ➝ $93.00	Neutral
TTE TotalEnergies	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$89.22 -1.1%	$90.00
TTG TT Electronics	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 150.40 +0.7%	GBX 115 ➝ GBX 160	Sector perform
TTGPF TT Electronics	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.89		Sector Perform
UBER Uber Technologies	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Pitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.04 -0.5%	$119.00
UBER Uber Technologies	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jake Fuller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.04 -0.5%	$100.00	Buy
UBER Uber Technologies	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor Manley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$76.04 -0.5%		Buy
UEC Uranium Energy	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.51 -0.9%	$11.50	Hold
VBNK VersaBank	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.59 +6.8%		Outperform
VBNK VersaBank	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.59 +6.8%	$20.00
VBNK VersaBank	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Irwin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.59 +6.8%	$28.00	Buy
VLO Valero Energy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.84 +1.3%	$329.00 ➝ $435.00	Overweight
VOXR Vox Royalty	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Reagor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.81 +4.3%	$7.75 ➝ $8.00	Buy
VSH Vishay Intertechnology	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.42 -0.6%	$42.00	Buy
WOOF Petco Health and Wellness	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.52 -4.2%	$2.34 ➝ $2.11	Underperform
WOOF Petco Health and Wellness	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Benedict Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.52 -4.2%	$3.00 ➝ $3.25	Neutral
WOOF Petco Health and Wellness	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.52 -4.2%	$4.00 ➝ $3.50	Neutral
WY Weyerhaeuser	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hong Zhang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.03 -0.7%	$31.00 ➝ $28.00	Overweight
WYFI WhiteFiber	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.78 +8.5%	$37.00	Buy
XNCR Xencor	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.62 -1.0%	$14.00 ➝ $21.00	Neutral
XOM ExxonMobil	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Royall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.28 -1.1%	$158.00 ➝ $185.00	Neutral
XPS XPS Pensions Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 313.50 +2.1%	GBX 469	Buy
ZTO ZTO Express (Cayman)	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.91 -0.2%	$29.00 ➝ $22.00	Overweight ➝ Neutral
ZYME Zymeworks	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.90 -3.7%	$31.00 ➝ $33.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:16 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings